Obituary Richard Simon, NCI’s visionary biostatistician, dies at 80 May 24, 2024Vol.50 No.21By Paul Goldberg
Capitol Hill As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25 May 24, 2024Vol.50 No.21By McKenzie Prillaman
NCI: Cancer center communicators are key to the success of the National Cancer Plan May 24, 2024Vol.50 No.21By Jacquelyn Cobb
Trials & Tribulations Are we focused on the wrong risk type in genetic screening?Breast cancer screening study shows new paths to population screening May 24, 2024Vol.50 No.21By Cassie Hajek
Guest Editorial Training programs for medical educators can overcome barriers in global oncologyHow an education program in Ethiopia increased access to cancer pain management May 24, 2024Vol.50 No.21By Ethan Dmitrovsky
FreeIn the Archives Waun Ki Hong, legend and “mentor magnificus,” in his own words May 24, 2024Vol.50 No.21
HRD results can vary widely, depending on what assay you choose—even as they guide treatment choices May 17, 2024Vol.50 No.20By Jacquelyn Cobb
Conversation with The Cancer Letter NCI’s Lisa McShane: We need to understand the implications of HRD assay discordance May 17, 2024Vol.50 No.20By Jacquelyn Cobb
RWE study pinpoints gaps in mental health care utilization among parents of children with cancer May 17, 2024Vol.50 No.20By McKenzie Prillaman
